Once upon a time (not so very long ago) Boniol et al. suggested that the 120-day mortality rate associated with biopsies for risk of prostate cancer might be as high as 1.3 percent. This caused something of a furore. In a new paper by Canat et al. — based on data from biopies carried out […]![]()
